Skip to content

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

Preoperative Radiotherapy and Concomitant Chemotherapy Followed by Surgery for Advanced Paranasal Sinus Carcinoma

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00347256
Enrollment
60
Registered
2006-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2008-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paranasal Sinus Neoplasms

Brief summary

The purpose of this study is to determine the efficacy of concurrent chemotherapy and radiotherapy pre-operatively in patients with advanced paranasal sinus cancer. The main objectives of this study are: 1) to measure the rate of complete response to preoperative chemoradiation and 2) to study the efficacy of combining preoperative chemoradiation and surgery in terms of local control of the cancer two years post treatment.

Interventions

DRUGcisplatin

Sponsors

North American Skull Base Society
CollaboratorOTHER
University of Tennessee
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Karnofsky Performance Score: \>= 60 * Creatinin clearance \>= 50 ml/min or serum creatinine =\<1.5 mg/dl * Total bilirubin, AST, ALT =\< 1.5 X laboratory uln * ANC \>= 2000/mm3, platelets \>= 100,000/mm3 * Serum calcium within normal range * T3 or T4 state tumors of paranasal sinuses * Squamous cell carcinoma, adenocarcinoma, high-grade mucoepidermoid carcinoma, sinonasal undifferentiated carcinoma

Exclusion criteria

* History of other malignancy in the last 3 years * Other serious comorbidity that may significantly reduce the survival in next 5 years * Pregnant or lactating women * History of radiation to the head and neck region * Paranasal sinus tumor is recurrent after prior treatment * Presence of cervical node metastasis * Presence of distant metastasis * Advanced nasopharyngeal malignancy with sphenoid or posterior ethmoid invasion

Design outcomes

Primary

MeasureTime frame
Local control of cancer at two years post treatment
Response to preoperative chemoradiation

Secondary

MeasureTime frame
Estimation of the overall survival and cumulative incidence of death due to disease at 2 years
Estimation of the proportion of the inoperable tumors which become operable after chemoradiation
Measurement of the accuracy of conventional imaging techniques (CT, MRI) compared with the addition of PET imaging in predicting the response to chemoradiation therapy.
Determination of the acute and long-term toxicity, particularly ophthalmologic complications, and surgical morbidity associated with this regimen
Identification of factors that are associated with inoperability

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026